BRIEF-Biomarin Pharma up 6.1 percent premarket; FDA panel backs approval of Morquio A Syndrome drug

NEW YORK, Nov 20 (Reuters) - BioMarin Pharmaceutical Inc (BMRN) : * Pharma up 6.1 percent premarket after FDA panel backs approval of Morquio A

Syndrome drug


(c) Reuters 2013. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.